(Q784717)

133040-01-4 (English)

18 November 2016

chemical formula

C₂₃H₂₄N₂O₄S

1 reference

133040-01-4 (English)

18 November 2016

canonical SMILES

CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O

1 reference

133040-01-4 (English)

18 November 2016

isomeric SMILES

CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O

1 reference

133040-01-4 (English)

https://www.whocc.no/atc_ddd_index/?code=C09CA02

18 November 2016

defined daily dose

0.6 gram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

eprosartan (English)

1 reference

eprosartan (English)

medical condition treated

3 October 2016

congestive heart failure

1 reference

13 December 2016

arterial hypertension

1 reference

significant drug interaction

13 December 2016

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

hypothetically

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

angiotensin II receptor type 1

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

588

LiverTox likelihood score

17 August 2016

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Eprosartan

last update

13 January 2017

subject has role

antihypertensive drug

1 reference

Medical Subject Headings

MeSH descriptor ID

C068373

angiotensin II type 2 receptor blockers

15 March 2018

1 reference

InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

Medical Subject Headings

15 March 2018

Eprosartan

0 references

Identifiers

InChI

1 reference

133040-01-4 (English)

18 November 2016

2 references

133040-01-4 (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

133040-01-4

2 references

eprosartan (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=133040-01-4

9 April 2021

1 reference

Eprosartan (English)

18 November 2016

2 references

133040-01-4 (English)

18 November 2016

Reaxys registry number

4338002

1 reference

eprosartan (English)

3 October 2016

mapping relation type

2 references

EPROSARTAN (English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

1 reference

EPROSARTAN (English)

18 November 2016

2 references

inferred from InChIKey

splash10-004i-0000900000-a93af7ff9cf5786971d0

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

splash10-056r-0171900000-4a8d34412967af4cbf35

0 references

splash10-052r-1971000000-ee85641cdce897ab6693

0 references

splash10-052r-1920000000-282ecc38e7c0c6cbefef

0 references

splash10-0a4i-1900000000-1a109162fa90e4ce7932

0 references

splash10-0a4i-2900000000-54946c90c1dfdf5eb21e

0 references

splash10-004i-0000900000-f33c4c2419ad566fa726

0 references

splash10-056r-1172900000-e0852717bfa6c5f8f0cd

0 references

splash10-052r-1970000000-fed4d418faa53031f6ca

0 references

splash10-052r-1920000000-2ddeec1f39e95c27109d

0 references

splash10-0a4r-1910000000-2953fc7d89567648d5ea

0 references

splash10-0a4i-1900000000-1e52f8edbad114f026d5

0 references

splash10-0a4l-0196300000-e398b1a8add5df82164b

0 references

splash10-004i-0009000000-fa421ee23b907968b800

0 references

splash10-00di-0002900000-694c481f9555295f9426

0 references

splash10-004u-0289000000-647b9ea41a7a812dea66

0 references

splash10-00kg-0290000000-08e189bdaeb9c6af3b4f

0 references

splash10-014j-1290000000-e8207e65f017389d706f

0 references

splash10-00lr-9260000000-7b844b75045cf89e145e

0 references

splash10-001i-9100000000-f49fc8384f38dc7b6e3b

0 references

splash10-00di-0002900000-e62e6d74d830487d0954

0 references

splash10-002u-0198000000-d571b7bcdbe9e3f7e69f

0 references

splash10-00kp-0290000000-0b7c3fe664812ce51596

0 references

splash10-014j-1090000000-85f4ee357273ee0268c0

0 references

splash10-001i-9240000000-8ed6c4fadafd173a2579

0 references

splash10-001i-9400000000-81bd0b20c45458b1bdec

0 references

splash10-004i-0009000000-0333ac2f95788dceda2c

0 references

HSDB ID

7521

1 reference

Hazardous Substances Data Bank

28 October 2019

EPROSARTAN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

Guide to Pharmacology Ligand ID

Eprosartan (English)

publication date

17 November 2015

588

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

588

IUPHAR/BPS Guide to PHARMACOLOGY

eprosartan (English)

18 November 2016

1 reference

5 February 2021

1 reference

Medical Subject Headings

14 March 2018

1 reference

eprosartan (English)

18 November 2016

1 reference

Human Metabolome Database ID

HMDB0015014

2 references

based on heuristic

inferred from InChIKey

2 references

eprosartan (English)

18 November 2016

MedlinePlus drug identifier

0 references

1 reference

eprosartan (English)

18 November 2016

0 references

1 reference

1 reference

eprosartan (English)

3 October 2016

1 reference

eprosartan (English)

3 October 2016

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

eprosartan (English)